Hi everyone,
To recap, my mother was diagnosed with stage IIIc ovarian cancer in February 2009. She went through 6 cycles of chemo (5 with IP/IV cisplatin / taxol, 1 with IV carbo/taxol). Her scan in July showed NED and her CA-125 went from 20 (at it's highest) to 4 (clearly it's not that great of a marker for her).
Now we are looking at trials to help her stay in remission. We initially considered the Xyotax study, but she was not a candidate because of her neuropathy. There is a study opening up at several centers around the country involving pazopanib (once a month for 12 months as maintenance). It's similar drug to avastin. It was recently approved for renal cancer I think.
Has anyone had any experience with pazopanib? I don't think many people in the US will because the trial is just opening, but if there is anyone in the UK / Europe or Australia who has had experience with this drug, please share.
Many thanks and God Bless,
Anne





Add to the discussion